Testosterone Retention Mechanism in Sertoli Cells: A Biochemical Perspective



Manjeet Kaur Gill-Sharma*
Neuroendocrinology Department (retired), National Institute for Research in Reproductive Health (ICMR), J. M. Street, Parel, Mumbai, 400012, India


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 787
Abstract HTML Views: 454
PDF Downloads: 506
ePub Downloads: 406
Total Views/Downloads: 2153
Unique Statistics:

Full-Text HTML Views: 408
Abstract HTML Views: 231
PDF Downloads: 224
ePub Downloads: 133
Total Views/Downloads: 996



© 2018 Manjeet Kaur Gill-Sharma.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

* Address correspondence to this author at the A-602, Winchester Apt, 2nd Cross Lane, Lokhandwala Complex, Andheri (W), Mumbai-400053, India, Tel: 9819 307 305; Email: manjitgill_sharma@rediffmail.com


Abstract

Mechanism(s) involved in regulating Intratesticular Testosterone levels (iT) have assumed importance in recent years, from the point of view of hormonal contraception. Contraceptives using Testosterone (T) in combination with Progestins (P), for more effective suppression of pituitary gonadotropins thereby iT, are not 100% effective in suppressing spermatogenesis in human males, likely due to pesrsistence of Intratesticular Dihydrotestosterone (iD) in poor-responders. Several lacunae pertaining to the mechanism of action of principal male hormone T during spermatogenesis remain to be resolved. Notably, the mechanism through which T brings about the stage-specific differentiation of germ cells lacking Androgen Receptors (AR). Testosterone is a highly anabolic steroid with a rapid tissue clearance rate. T is intratesticular substrate for synthesis of Dihydrotestosterone (DHT) and Estradiol (E2) involved in spermtaogenesis. Therefore, it is important to delineate the mechanism(s) for retention of iT, in order to understand regulation of its bioavailability in testis. In depth studies, pertaining to the role of androgen-binding protein(s) in sequestration, retention and bioavailability of T/DHT are required to understand male fertility regulation. The appropriate approach to overcome this lacuna would be development of mice lacking functional testicular Androgen-Binding Protein (ABPKO), but not deficient T/DHT, Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH), in order to understand its physiological functions. Insights gained about androgen retention mechanism(s) from the ABPKO murine model will be of immense help in improving the efficacy of male hormonal contraceptives and infertility management.

Keywords: Testosterone, Androgen-binding protein, Sex hormone-binding globulin, Megalin, Sertoli cell, Spermatogenesis.



1. INTRODUCTION

Testosterone (T) is a lipophilic steroidal molecule synthesized in the interstitial cells of Leydig in the testis. Androgen-Binding Protein (ABP)/SHBG sequester and solubilize serum T to facilitate transport and iT bioavailability [1]. Most mammalian species express a testicular protein that specifically binds androgens T/DHT (dihydrotestosterone) with high affinity [2]. The mechanism for storage of intratesticular testosterone (iT), at a level several folds higher than that in circulation, however, awaits delineation. The rapidity with which the sequestered androgens dissociate from ABP suggests that it could be regulating T/DHT bioavailability at testicular Androgen Receptors (AR) [3]. This hypothesis, however, awaits experimental substantiation.

1.1. Role of Testosterone (T) in Male Fertility Regulation

Testosterone Radioimmunoassays (RIA) demonstrated that a plasmatic circadian T acrophase occurred in human subjects between 1-5h [4]. The crucial role of T in spermatogenesis became evident in rats treated with AR blocker, Cyproterone Acetate (CPA). Evaluation of sperm chromatin structure by flow cytometry demonstrated that Sertoli cell AR blockade prevented initiation of chromatin condensation in elongating spermatids. AR blockade reduced the fertility of male rats due to the production of poor quality epididymal spermatozoa, deficient in thiols and protamine1 [5]. Testosterone RIAs demonstrated that tamoxifen treatment reduced the levels of intratesticular androgens in adult male rat concomitant with a reduction in their siring ability [6]. Testosterone can also act to regulate spermatogenesis via its non-aromatizable metabolite, Dihydrotestosterone (DHT) and estradiol (E2), its aromatizable metabolite [7, 8]. Plasmatic hormone RIAs also demonstrated that a circadian E2 acrophase occurred in human subjects between 13-18h [4]. The role of E2 in fertility regulation became evident from several studies. Estrogen Receptor (ESR1) gene null mutation led to sterility in mice [9]. Steroid hormone RIAs demonstrated that high intratesticular E2 (iE) levels produced in E2-treated rats reduced intratesticular androgens, disrupted the formation of Tubulobulbar Complexes (TBCs) and led to spermiation failure. This study revealed plasmatic E2 uptake by the Sertoli cells [10, 11]. Histology of testes of estradiol-treated rats revealed a reduction in the height of Sertoli cells, attributed to lack of polymerization of cytoskeletal protein Vimentin [12, 13]. Confocal Microscopy subsequently confirmed disorganization of Sertoli cell Vimentin in E2-treated rat testis [14]. Stimulation of ESR1 and ESR2 with specific agonists PPT (4, 40, 4”-(4- Propyl-[1H] pyrazole-1, 3, 5-triyl) and DPN (2, 3-bis (4-hydroxyphenyl)-propionitrile) respectively, reduced the fertility of male rats [15]. ESR1 agonist reduced the sperm counts, evaluated by flow cytometry of testicular cells, through suppression of plasmatic gonadotropins and testosterone. Reduced T levels led to arrest of conversion of round to elongating spermatids, owing to downregulation of chromatin condensation proteins. ESR2 agonist reduced sperm counts through germ cell apoptosis, evaluated by TUNEL assay and caused spermiation failure [16]. It is tempting to suggest that E2 could be playing an autoregulatory physiological role in the predominantly androgen-dependent biological process of spermatogenesis.

1.2. Significance of High Concentration of Intratesticular Testosterone (IT)

Intratesticular T is the most decisive hormone for maintenance of qualitative spermatogenesis in mammals [17]. Natural and genetically engineered mutant mice have contributed to the delineation of T- dependent stages of spermatogenesis. Congenital deficiency of T in hpg mice blocked the first meiotic division and arrested spermatogenesis at pre-meiotic spermatocyte stage, reversible with T implants [18]. The significant finding that emerged from T supplementation studies was that Sertoli cells internalized steroidal molecules from the peripheral circulation. Genetic mutant studies suggested the involvement of Sertoli cell AR in mediating T effect on round spermatid adhesion and development. The arrest of spermatogenesis at pachytene stage in Androgen Receptor Knockout (ArKO) mice indicated the role of AR in adhesion of round spermatids to Sertoli cells [19]. The absence of elongating spermatids in testis of SCARKO mice unequivocally implicated Sertoli cell AR in spermiogenesis [20].

Sertoli cell iT has been implicated in the expression of adhesion-related genes namely, Rhox5, N-cadherin, connexin-43, gelsolin, laminin-γ3, occludin, testin, nectin, zyxin and vinculin [21, 22]. Androgen Response Elements (ARE) were demonstrated by chromatin immunoprecipitation in the promoters of Sertoli cell genes, namely phosphatidylinositol binding clathrin assembly protein, early endosomal autoantigen1 and syntaxin, in the testis of estrogen-treated rats [23]. The adverse effect of blocking Sertoli cell AR on germ cell genes namely Protamine1, histone deacetylase1, ubiquitin ligating enzyme, 20S proteasome α1, 5-methyl cap binding RNA-binding protein, ubiquitin-activating and conjugating enzymes, chromodomain Y-like protein, bromodomain testis-specific protein, histone deacetylase 6, histones h2b and h3, was demonstrated by RT-PCR [24]. Thus, high levels of iT are essential for mediating its molecular effects via Sertoli cell AR.

1.3. Significance of Intratesticular Testosterone (IT) Storage Mechanism to Spermatogenesis

Several studies suggested that a functional relationship exists between iT levels in Sertoli cells and differentiation of spermatozoa. CHIP (chromatin immunoprecipitation) assay demonstrated that T and its metabolites regulated testicular genes involved in actin remodeling and endocytosis, in the testis of E2 treated rats. Liganded to AR and ER beta-receptors, T and E2 recruited coregulators NcoRI, Src1 to AREs and EREs in the promoters of Picalm, Eea1, Stx5a and Arpc1b, Evl testicular genes, respectively. The presence of a storage protein could be crucial for ensuring T bioavailability for gene transcription during spermatogenesis. Testosterone and its metabolites, liganded to AR and ER beta-receptors, recruited coregulators NcoRI, Src1 to AREs and EREs in the promoters of Picalm, Eea1, Stx5a and Arpc1b, Evl testicular genes, respectively as [25]. Histological and Confocal Microscopic evaluation of the testis of E2-treated rats revealed that reduction in iT levels had affected organization of Sertoli cell cytoskeletal Vimentin [12-14]. Flow cytometric evaluation of monobromobimane (mBBr) fluorescent dye uptake by epididymal sperm, taken from CPA- and E2-treated rats, indicated a reduction in sperm thiols, thus an altered oxidation status [5, 26]. Immunoblotting studies of E2-treated rat testis also revealed reduced levels of CREMτ (cyclic AMP response element modulator), transition proteins and protamine [26].

The occurrence of plasmatic T internalization emerged from studies of T (0.3cm) and E (0.4cm) implanted (TE) rats. TE implants suppressed the cytodifferentiation of stage VII and VIII round spermatids to 16% of controls within eleven weeks. T (24cm) implants restored the arrested cytodifferentiation within four days, ostensibly by internalizing T from peripheral circulation [7]. Failure of this restorative effect to occur in the presence of either flutamide (AR Antagonist) or L685, 273 (5alpha-reductase inhibitor) revealed the significance of bioavailability of intratesticular DHT (iD) [8]. Several studies indicated the existence of an FSH-dependent mechanism that modulates androgen responsiveness of Sertoli cells [27-29]. Supplementation of gonadotropin-deficient (hpg) mutant mice with recombinant FSH (rhFSH) and T implants (0.125-1cm), followed by stereological evaluation of mutant testis revealed that FSH mediated the proliferation of pre-meiotic spermatogenic cells, ostensibly by generating the mitogenic hormone iE from iT stores [30, 31]. Immunohistochemical localization of Bromodeoxyuridine (BrdU) in spermatogonial DNA of E2-treated rat testis had demonstrated its mitotic role [12]. Steorological evaluation of testis of LurKO, ARKO and SCARKO genetic mutant mice with disrupted androgen signalling indicated that FSH could maintain spermatogonial population [19, 20, 32]. FSH apparently produced a mitotic effect on spermatogonia via aromatization of iT to iE. Real-time PCR studies in rats treated with specific agonists of estrogen receptors demonstrated a direct testicular role of iE. These studies detected reductions in transcripts of transition proteins, protamine1, Arpc1b, Evl, Picalm, Bcl2, Bclw, cyclin A1 and B1spermatidal genes in adult male rats with specific agonists of ESRI/2 (PPT and DPN). These studies confirmed the role of iE via testicular estrogen receptors ESR1 and ESR2 [16, 33].

Therefore, maintenance of high iT levels is necessary for the synthesis of iD and iE required for efficient spermatogenesis. A mechanism for storage of T in the testis would be of physiological relevance due to its lipophilic nature, high tissue clearance rates and circadian secretion. Most importantly, the circadian peak of T necessitates a testicular mechanism of retention and storage, in order to meet the physiological need of spermatogenesis for iD/iE.

1.4. Mechanistic Role of Androgen-Binding Protein(s) in Testosterone Retention

Sub-human mammals express a specific androgen-binding protein (ABP) of hepatic and testicular origin, besides a non-specific albumin carrier protein for plasmatic T [2]. Homo sapiens express an identical plasmatic Sex-Hormone-Binding Globulin (SHBG) of hepatic origin [1]. Albumin and androgen-binding proteins present in Systemic Circulation sequester T. ABP and SHBG are high-affinity, androgen-binding proteins, expressed from a conserved shbg gene, in a tissue-specific manner, in human and sub-human mammals, respectively. Sertoli cells secrete ABP bidirectionally into serum and seminiferous tubular fluid in rats, regulated by FSH [3, 34, 35]. Since human SHBG is of hepatic origin, the underlying reason for CREM-induced expression of a steroid-binding shbg transcript, in the acrosomes of human spermatids, is not comprehensible [36]. Radioimmunoassays detected ten-fold higher iT as compared to plasmatic T. This feature, common to all mammals, is suggestive of the existence of a common physiological mechanism for iT retention and storage in Sertoli cells. However, non-expression of human SHBG in Sertoli cells defies this logic for gaining access to ARs. SHBG is purported to mediate plasmatic T signals via alternative routes [37]. Megalin is a transmembrane receptor involved in uptake of sex steroids in tissues. Megalin deficiency was immunohistochemically confirmed in the testis of megalin null mice. Megalin null mice present with cryptorchidism. Male Megalin null mutant mice have reduced expression of several androgen inducible genes namely, Tex12, Morc, Stk25, Ramp2 and increased expression of androgen-repressed genes namely, Mpo, Igfbp5 [38]. SHBG can bind and transport plasmatic T into sex-steroid dependent tissues via Megalin receptors [39]. SHBG can also transduce plasmatic T signalling by binding to specific, non-genomic SHBG receptors expressed on the plasma membrane [40, 41].

Transgenic mice overexpressing ABP in Sertoli cells, expressed the protein from 5.5 Kb genomic DNA regions, comprising coding and 1.5 Kb regions upstream of transcription start site of rat ABP/SHBG gene [42, 43]. ABP overexpression, however, led to upregulation of aromatase and ESR2 in germ cells. Histological assessment of ABP h transgenic mouse testis revealed apoptosis of germ cells arrested at meiotic stage. These pathophysiological effects are characteristic of E2 exposure, seen in rats treated with specific ESR1 and ESR2 receptor agonists [15, 33, 44, 45]. The phenotype of ABP transgenic mouse model overlaps with those of PPT/DPN-treated rat models. Both iT and iE upregulated ABP levels in Sertoli cells of rat testis. ABP transcripts were downregulated in CPA-treated rat testis, ostensibly by accelerating autophagic clearance [5, 46]. ABP transcripts were also upregulated in E2-treated rat testis albeit downregulated in tamoxifen-(estrogen receptor antagonist) treated rat testis [26, 47]. These studies suggest an autoregulatory role of iT and iE in iT retention and regulation of bioavailability for spermatogenesis. Therefore, the role of ABP in iT storage/retention needs to be demonstrated in the ABP gene knock out mouse model.

2. PUTATIVE STRATEGY TO STUDY ROLE OF INTRATESTICULAR TESTOSTERONE (IT) SEQUESTRATION MECHANISM

Gene ablation would be a far better approach to study functions of proteins that upregulate target genes. Blocking Sertoli cell ARs with CPA is the pharmacological equivalent of AR gene ablation. The observed downregulation of the transcripts of several testicular genes, involved in the process of spermatid chromatin condensation during spermiogenesis, in CPA-treated rats, supports this logic [24]. Indeed, the observed upregulation of ESR1 and aromatase, concomitant with meiotic arrest and germ cell apoptosis in testis of ABP transgenic mice were pathophysiological estrogenic effects of ABP overexpression [44, 45, 48]. ABP transgenic mice presented with a phenotype that overlapped with those observed after pharmacological stimulation of germ cell ESR1/2 in rats [15, 16, 33, 44, 45, 48]. Ostensibly, gene overexpression approach failed to demonstrate the physiological role of ABP in iT retention and storage. Development of mice lacking androgen-binding protein would be the ideal approach to study its role in iT retention and storage [3]. However, in order to overcome the potential developmental problems of viability and cryptorchidism, a conditional knockout of Sertoli cell shbg gene would be an appropriate approach to study the role of ABP in iT retention and spermatogenesis.

2.1. Structure of Murine Androgen-Binding Protein

Sex hormone-binding globulin (shbg) gene located on chromosome 11 encodes murine ABP in CDI mouse testis [49]. The 3Kb coding region expresses a 1.7Kb transcript that encodes a 4.4539Kd precursor protein, comprising 403 amino acids in eight exons. Cleavage of a signal peptide from the N-terminus of the precursor protein generates a mature 4.1183Kd protein comprising 373 residues [35]. Photoaffinity labeling identified the steroid-binding region in residues 141-150 in rat protein [50]. Expression of human SHBG deletion mutants in E coli identified amino acid residues 18-177 to be involved in steroid binding [2, 51, 52]. Two promoters regulate tissue-specific expression of murine ABP [53, 54]. P1 promoter expresses the protein from exons 1-8 in the testis. An alternative promoter upstream of P1 expresses hepatic and cerebral ABP [35, 55, 56]. The androgen-binding protein essentially exists as a dimer comprising differentially glycosylated protomers [57]. ABP/SHBG has three conserved glycosylation sites, two of Asn at the carboxyl-terminus and one of O-glycosylation in the amino-terminus [58, 59]. Binding affinity comparison of purified SHBG/ABP with digested protein fragments of prostate receptor also identified a conserved receptor-binding domain between amino acid residues 48-57 [41].

2.1.1. Ablation of Androgen-Binding Region in Murine shbg Gene

Murine shbg gene (NT 096135) is 3816bp in length and encodes testicular ABP mRNA (U 8564, 1369bp in length. Exons 1-8 of murine ABP express testicular ABP proprotein composed of 403 amino acids, inclusive of signal peptide. Signal peptide cleavage in the endoplasmic reticulum during translation produces a mature protein comprising 373 amino acids [35, 49]. The mature protein undergoes post-translational modifications and is N-glycosylated at two positions. Glycosylation ensures a secretory role but is not a pre-requisite for steroid binding [57, 60]. The steroid-binding site of SHBG in each protomer is highly conserved in amino-terminal LG domain encoded by exons 2-5. Crystal structure of SHBG monomer, determined from N-terminal G domain polypeptide expressed in E Coli, revealed that DHT intercalates into a hydrophobic pocket between two anti-parallel β-sheets [61]. Ser42 in the amino-terminal LG domain of human SHBG is critical for binding steroids [62, 63]. Deletion of the androgen-binding region of shbg gene would affect the binding of iT/iD to ABP while retaining the androgen-independent functions of ABP [40]. Therefore, development of mice lacking the steroid-binding domain would be an effective strategy for studying the role of ABP in T retention, iT storage and spermatogenesis. Most importantly, retained glycosylation sites will not affect the secretion of the mutant protein. Southern blotting, immunohistochemistry, Western blotting and RIA will confirm the efficacy of ablation of shbg transcripts and ABP protein. The mutant model will also provide information about the independent role, if any, of ABP molecule in spermatogenesis. A systematic evaluation of iT targets in conditional ABPKO mice lacking T binding domain will reveal the effects of breakdown of the mechanism of iT retention and storage on spermatogenesis at adulthood.

2.2. Proposed Comparative Mechanism for Transport, Sequestration and Retention of Intratesticular T (iT) in Human and Rat Sertoli Cells (Fig. 1):

Leydig cells secrete lipophilic hormone T in peripheral circulation [64, 65]. T ostensibly could interact with Sertoli cells through several pathways. Conventional mechanism of intravascular T action involving induction of Calcium influxes via non-genomic AR on Sertoli cells leading to CaM/CaMKIV/CREB activation [66-69]. Another mechanism would involve activation of intracellular signaling via SHBG-receptor (SHBGR) complex on plasma membrane of Sertoli cells [40]. Free T could enter Sertoli cells by diffusion but its lipophilic nature would limit intracellular bioavailability [61]. A more plausible pathway for T to enter Sertoli cells would be via endocytosis of vascular androgen-binding protein(s). The binding protein(s) would solubilize the lipophilic T and that would ensure bioavailability at nuclear AR. Indeed, sex steroid dependent tissues express transmembrane receptor megalin for endocytosis of plasmatic sex steroids. Sertoli cells do internalize sex steroids via megalin since Megalin receptor null mice have developmental defects like cryptorchid testis [38]. Sertoli cell aromatase and 5alpha-reductase enzymes aromatize or reduce iT to iE and iD, respectively. T/iD and iE act via nuclear AR and ER for gene expression. Germ cells express ER but not AR. ABP would transport iT to germ cells for aromatization to generate E2. E2 regulates several germ cell genes via EREs (demonstrated by CHIP assays), including repressed transcripts TPs and P (demonstrated by real-time PCR) in PPT/DPN-treated rats, that are eventually stored in the chromatoid body [15, 16, 33, 70]. It is tempting to speculate that germ cells may also endocytose SHBG/ABP via putative transmembrane receptors. Human germ cell lineages express a non-secretory variant of SHBG (aSHBG). ASHBG variant retains T binding function though the physiological relevance is not evident. ASHBG/ABP could serve as iT storage molecule in germ cells. It could also protect germ cells from excess iE exposure (akin to protection of developing fetus from overexposure to T).

Fig. (1). Schematic mechanism for androgen retention in rat Sertoli cells.

CONCLUSION

It is important to delineate the physiological mechanism(s) involved in sequestration and retention of iT and iD in mammalian Sertoli cells. Testosterone regulates expression of Sertoli cell genes involved in spermatogenesis. Testosterone is a lipophilic steroid hormone. The hydrophobic nature would render it insoluble in the hydrophilic cytosol and limit accessibility to nuclear AR. Most mammals’ express specific androgen-binding proteins for intravascular and intracellular retention of T. Androgen-binding proteins solubilize T/DHT. However, the mechanism of Sertoli cell iT storage awaits elucidation. Overexpression of ABP in transgenic mice led to upregulation of germ cell estrogenic mechanism. Therefore, development of conditional ABP null mice would be an inherently superior approach to delineate the mechanism of iT retention and storage in testis.

LIST OF ABBREVIATIONS (FIG 1):

ABP = Androgen binding protein
aSHBG = Alternative transcript of SHBG
AC = Adenyl cyclase
AJ = Adhesion junctions
AR = Androgen receptor
Arm = Aromatase
Ca = Calcium
CaM = Calcium modulated protein
CamKIV = Calmodulin kinaseIV
CB = Chromatoid body
CH = Condensed chromatin
cre = cyclicAMP response element
CREB = CyclicAMP response element-binding protein
DHT = Dihydrotestosterone
E2 = Estradiol
ERE = Estrogen response element
ER = Endoplasmic reticulum
ER' = Estrogen receptor
ES = Ectoplasmic specialization
FSH = Follicle stimulating hormone
GC = Germ cell
GCN = Germ cell nucleus
M = Megalin
P = Protamine;
PKA = Protein kinase A
Red = 5alpha-reductase
SC = Sertoli cell
SCN = Sertoli cell nucleus
SHBG = Sex hormone-binding globulin
SHBGR = SHBG receptor
T = Testosterone
TP = Transition proteins

CONSENT FOR PUBLICATION

Not applicable.

CONFLICT OF INTEREST

The authors declare no conflict of interest, financial or otherwise.

ACKNOWLEDGEMENTS

I dedicate this paper to late Dr J.C Herr (Director of CRCRH, Dept of Cell Biology, Charlottesville, VA, USA) whose abiding research passion was sperm Proteomics and testicular Genomics. I am grateful to him for providing me the opportunity to work in his lab and develop a targetting construct for testicular CABYR (calcium-binding tyrosine-regulated) gene, for development of CABYR knockout mouse, by homologus recombination approach. Dr Ansari M Aleem (Visiting Associate Researcher, Chemistry and Biochemistry Department, 295 PSB, Thimann Receiving University of California, Santa Cruz, Santa Cruz, CA 95064, U.S.A. Email: amaleem@ucsc.edu) and Sidhant Sharma (MS), Samsung, Sunnyvale, CA, (U.S.A) are acknowledged for creative and financial assistance for the illustration. I am grateful to the Editorial Board of The Open Biochemistry Journal for a waiver of publication charges.

REFERENCES

[1] Fortunati N. Sex hormone-binding globulin: Not only a transport protein. What news is around the corner? J Endocrinol Invest 1999; 22(3): 223-34.
[2] Munell F, Suárez-Quian CA, Selva DM, Tirado OM, Reventós J. Androgen-binding protein and reproduction: Where do we stand? J Androl 2002; 23(5): 598-609.
[3] Robaire B, Hinton BT. The epididymis.The Physiology of Reproduction 2015; 691-771.
[4] Juneja HS, Karanth S, Dutt A, Parte P, Meherjee P. Diurnal variations and temporal coupling of bioactive and immunoactive luteinizing hormone, prolactin, testosterone and 17-beta-estradiol in adult men. Horm Res 1991; 35(3-4): 89-94.
[5] Aleem M, Padwal V, Choudhari J, Balasinor N, Parte P, Gill-Sharma M. Cyproterone acetate affects protamine gene expression in the testis of adult male rat. Contraception 2005; 71(5): 379-91. a
[6] Parte P, Balasinor N, Gill-Sharma MK, Maitra A, Juneja HS. Temporal effect of tamoxifen on cytochrome P450 side chain cleavage gene expression and steroid concentration in adult male rats. J Steroid Biochem Mol Biol 2002; 82(4-5): 349-58.
[7] O’Donnell L, McLachlan RI, Wreford NG, Robertson DM. Testosterone promotes the conversion of round spermatids between stages VII and VIII of the rat spermatogenic cycle. Endocrinology 1994; 135(6): 2608-14.
[8] O’Donnell L, Pratis K, Stanton PG, Robertson DM, McLachlan RI. Testosterone-dependent restoration of spermatogenesis in adult rats is impaired by a 5alpha-reductase inhibitor. J Androl 1999; 20(1): 109-17.
[9] Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA 1993; 90(23): 11162-6.
[10] D’Souza R, Gill-Sharma MK, Pathak S, Kedia N, Kumar R, Balasinor N. Effect of high intratesticular estrogen on the seminiferous epithelium in adult male rats. Mol Cell Endocrinol 2005; 241(1-2): 41-8.
[11] D’Souza R, Pathak S, Upadhyay R, et al. Disruption of tubulobulbar complex by high intratesticular estrogens leading to failed spermiation. Endocrinology 2009; 150(4): 1861-9.
[12] Choudhuri J, Aleem M, Padwal V, et al. Effect of estradiol on expression of cytoskeletal proteins during spermatogenesis in testis of sexually mature rats. Indian J Exp Biol 2005; 43(11): 1068-79.
[13] Show MD, Anway MD, Folmer JS, Zirkin BR. Reduced intratesticular testosterone concentration alters the polymerization state of the Sertoli cell intermediate filament cytoskeleton by degradation of vimentin. Endocrinology 2003; 144(12): 5530-6.
[14] Upadhyay RD, Kumar AV, Sonawane S, Gaonkar R, Balasinor NH. Estrogen effects on actin cytoskeletal and endocytic proteins associated with tubulobulbar complex disruption in rat testes. Reprod Sci 2013; 20(10): 1162-74.
[15] Dumasia K, Kumar A, Kadam L, Balasinor NH. Effect of estrogen receptor-subtype-specific ligands on fertility in adult male rats. J Endocrinol 2015; 225(3): 169-80.
[16] Dumasia K, Kumar A, Deshpande S, Sonawane S, Balasinor NH. Differential roles of estrogen receptors, ESR1 and ESR2, in adult rat spermatogenesis. Mol Cell Endocrinol 2016; 428: 89-100.
[17] Ramaswamy S, Weinbauer GF. Endocrine control of spermatogenesis: Role of FSH and LH/ testosterone. Spermatogenesis 2015; 4(2): e996025.
[18] Handelsman DJ, Spaliviero JA, Simpson JM, Allan CM, Singh J. Spermatogenesis without gonadotropins: Maintenance has a lower testosterone threshold than initiation. Endocrinology 1999; 140(9): 3938-46.
[19] Yeh S, Tsai MY, Xu Q, et al. Generation and characterization of Androgen Receptor Knockout (ARKO) mice: An in vivo model for the study of androgen functions in selective tissues. Proc Natl Acad Sci USA 2002; 99(21): 13498-503.
[20] De Gendt K, Swinnen JV, Saunders PT, et al. A Sertoli cell-selective knockout of the androgen receptor causes spermatogenic arrest in meiosis. Proc Natl Acad Sci USA 2004; 101(5): 1327-32.
[21] MacLean JA, Chen MA, Wayne CM, et al. Rhox: A new homeobox gene cluster. Cell 2005; 120(3): 369-82.
[22] Zhang C, Yeh S, Chen YT, et al. Oligozoospermia with normal fertility in male mice lacking the androgen receptor in testis peritubular myoid cells. Proc Natl Acad Sci USA 2006; 103(47): 17718-23.
[23] Kumar A, Dumasia K, Gaonkar R, Sonawane S, Kadam L, Balasinor NH. Estrogen and androgen regulate actin-remodeling and endocytosis-related genes during rat spermiation. Mol Cell Endocrinol 2015; 404: 91-101.
[24] Gill-Sharma MK, Choudhuri J, Ansari MA, D’Souza S. Putative molecular mechanism underlying sperm chromatin remodelling is regulated by reproductive hormones. Clin Epigenetics 2012; 4(1): 23.
[25] Kumar A, Dumasia K, Deshpande S, Balasinor NH. Direct regulation of genes involved in sperm release by estrogen and androgen through their receptors and coregulators. J Steroid Biochem Mol Biol 2017; 171: 66-74.
[26] Aleem M, Padwal V, Choudhari J, Balasinor N, Parte P, Gill-Sharma MK. Estradiol affects androgen-binding protein expression and fertilizing ability of spermatozoa in adult male rats. Mol Cell Endocrinol 2006; 253(1-2): 1-13.
[27] McLachlan RI, O’Donnell L, Meachem SJ, et al. Identification of specific sites of hormonal regulation in spermatogenesis in rats, monkeys, and man. Recent Prog Horm Res 2002; 57: 149-79.
[28] Brinkworth MH, Weinbauer GF, Schlatt S, Nieschlag E. Identification of male germ cells undergoing apoptosis in adult rats. J Reprod Fertil 1995; 105(1): 25-33.
[29] Walker WH, Cheng J. FSH and testosterone signaling in Sertoli cells. Reproduction 2005; 130(1): 15-28.
[30] Singh J, O’Neill C, Handelsman DJ. Induction of spermatogenesis by androgens in gonadotropin-deficient (hpg) mice. Endocrinology 1995; 136(12): 5311-21.
[31] Singh J, Handelsman DJ. The effects of recombinant FSH on testosterone-induced spermatogenesis in gonadotrophin-deficient (hpg) mice. J Androl 1996; 17(4): 382-93.
[32] Lei ZM, Mishra S, Ponnuru P, Li X, Yang ZW, Rao ChV. Testicular phenotype in luteinizing hormone receptor knockout animals and the effect of testosterone replacement therapy. Biol Reprod 2004; 71(5): 1605-13.
[33] Dumasia K, Kumar A, Deshpande S, Balasinor NH. Estrogen signaling, through estrogen receptor β, regulates DNA methylation and its machinery in male germ line in adult rats. Epigenetics 2017; 12(6): 476-83.
[34] Sharpe RM. Regulation of spermatogenesis.The Physiology of Reproduction 1994; 1363-434.
[35] Joseph DR. Structure, function, and regulation of androgen-binding protein/sex hormone-binding globulin. Vitam Horm 1994; 49: 197-280.
[36] Selva DM, Hogeveen KN, Seguchi K, Tekpetey F, Hammond GL. A human sex hormone-binding globulin isoform accumulates in the acrosome during spermatogenesis. J Biol Chem 2002; 277(47): 45291-8.
[37] Frairia R, Fortunati N, Fissore F, et al. The membrane receptor for sex steroid binding protein is not ubiquitous. J Endocrinol Invest 1992; 15(8): 617-9.
[38] Hammes A, Andreassen TK, Spoelgen R, et al. Role of endocytosis in cellular uptake of sex steroids. Cell 2005; 122(5): 751-62.
[39] Hryb DJ, Khan MS, Romas NA, Rosner W. The control of the interaction of sex hormone-binding globulin with its receptor by steroid hormones. J Biol Chem 1990; 265(11): 6048-54.
[40] Rosner W, Hryb DJ, Kahn SM, Nakhla AM, Romas NA. Interactions of sex hormone-binding globulin with target cells. Mol Cell Endocrinol 2010; 316(1): 79-85.
[41] Khan MS, Hryb DJ, Hashim GA, Romas NA, Rosner W. Delineation and synthesis of the membrane receptor-binding domain of sex hormone-binding globulin. J Biol Chem 1990; 265(30): 18362-5.
[42] Reventos J, Sullivan PM, Joseph DR, Gordon JW. Tissue-specific expression of the rat androgen-binding protein/sex hormone-binding globulin in transgenic mice. Delineation and synthesis of the membrane receptor-binding domain of sex hormone-binding globulin. Mol Cell Endocrinol 1993; 96(1-2): 69-73.
[43] Esteban C, Gérard A, Larrib S, Torán N, Gérard H, Reventós J. Sertoli cell-specific expression of rat androgen-binding protein in transgenic mice: Effects on somatic cell lineages. Mol Cell Endocrinol 1997; 132(1-2): 127-36.
[44] Selva DM, Tirado OM, Toràn N, Suárez-Quian CA, Reventós J, Munell F. Meiotic arrest and germ cell apoptosis in androgen-binding protein transgenic mice. Endocrinology 2000; 141(3): 1168-77.
[45] Jeyaraj DA, Grossman G, Weaver C, Petrusz P. Dynamics of testicular germ cell proliferation in normal mice and transgenic mice overexpressing rat androgen-binding protein: A flow cytometric evaluation. Biol Reprod 2002; 66(4): 877-85.
[46] Ma Y, Yang HZ, Xu LM, Huang YR, Dai HL, Kang XN. Testosterone regulates the autophagic clearance of androgen binding protein in rat Sertoli cells. Sci Rep 2015; 5: 8894.
[47] Aleem M, Padwal V, Choudhari J, Balasinor N, Parte P, Gill-Sharma M. Effects of tamoxifen citrate on gene expression during nuclear chromatin condensation in male rats. Asian J Androl 2005; 7(3): 311-21. b
[48] Jeyaraj DA, Grossman G, Petrusz P. Dynamics of testicular germ cell apoptosis in normal mice and transgenic mice overexpressing rat androgen-binding protein. Reprod Biol Endocrinol 2003; 1: 48.
[49] Wang YM, Sullivan PM, Petrusz P, Yarbrough W, Joseph DR. The androgen-binding protein gene is expressed in CD1 mouse testis. Mol Cell Endocrinol 1989; 63(1-2): 85-92.
[50] Danzo BJ, Parrott JA, Skinner MK. Analysis of the steroid binding domain of rat androgen-binding protein. Endocrinology 1991; 129(2): 690-6.
[51] Hildebrand C, Bocchinfuso WP, Dales D, Hammond GL. Resolution of the steroid-binding and dimerization domains of human sex hormone-binding globulin by expression in Escherichia coli. Biochemistry 1995; 34(10): 3231-8.
[52] Avvakumov GV, Grishkovskaya I, Muller YA, Hammond GL. Resolution of the human sex hormone-binding globulin dimer interface and evidence for two steroid-binding sites per homodimer. J Biol Chem 2001; 276(37): 34453-7.
[53] Sullivan PM, Wang YM, Joseph DR. Identification of an alternate promoter in the rat androgen-binding protein/sex hormone-binding globulin gene that regulates synthesis of a messenger RNA encoding a protein with altered function. Mol Endocrinol 1993; 7(5): 702-15.
[54] Fenstermacher DA, Joseph DR. DNA sequences and their binding proteins required for Sertoli cell-specific transcription of the rat androgen-binding protein gene. Mol Endocrinol 1997; 11(9): 1387-400.
[55] Joseph DR, Sullivan PM, Wang YM, Millhorn DE, Bayliss DM. Complex structure and regulation of the ABP/SHBG gene. J Steroid Biochem Mol Biol 1991; 40(4-6): 771-5.
[56] Bocchinfuso WP, Ma KL, Lee WM, Warmels-Rodenhiser S, Hammond GL. Selective removal of glycosylation sites from sex hormone-binding globulin by site-directed mutagenesis. Endocrinology 1992; 131(5): 2331-6.
[57] Danzo BJ, Black JH, Bell BW. Analysis of the oligosaccharides on androgen-binding proteins: implications concerning their role in structure/function relationships. J Steroid Biochem Mol Biol 1991; 40(4-6): 821-31.
[58] Hammond GL, Underhill DA, Rykse HM, Smith CL. The human sex hormone-binding globulin gene contains exons for androgen-binding protein and two other testicular messenger RNAs. Mol Endocrinol 1989; 3(11): 1869-76.
[59] Hammond GL. Diverse roles for sex hormone-binding globulin in reproduction. Biol Reprod 2011; 85(3): 431-41.
[60] Joseph DR, Becchis M, Fenstermacher DA, Petrusz P. The alternate N-terminal sequence of rat androgen-binding protein/sex hormone-binding globulin contains a nuclear targeting signal. Endocrinology 1996; 137(3): 1138-43.
[61] Grishkovskaya I, Avvakumov GV, Sklenar G, Dales D, Hammond GL, Muller YA. Crystal structure of human sex hormone-binding globulin: steroid transport by a laminin G-like domain. EMBO J 2000; 19(4): 504-12.
[62] Grishkovskaya I, Avvakumov GV, Hammond GL, Catalano MG, Muller YA. Steroid ligands bind human sex hormone-binding globulin in specific orientations and produce distinct changes in protein conformation. J Biol Chem 2002; 277(35): 32086-93.
[63] Avvakumov GV, Cherkasov A, Muller YA, Hammond GL. Structural analyses of sex hormone-binding globulin reveal novel ligands and function. Mol Cell Endocrinol 2010; 316(1): 13-23.
[64] Payne AH. Hormonal regulation of cytochrome P450 enzymes, cholesterol side-chain cleavage and 17 alpha-hydroxylase/C17-20 lyase in Leydig cells. Biol Reprod 1990; 42(3): 399-404.
[65] Shi JF, Li YK, Ren K, Xie YJ, Yin WD, Mo ZC. Characterization of cholesterol metabolism in Sertoli cells and spermatogenesis (Review). Mol Med Rep 2018; 17(1): 705-13. [review].
[66] Loss ES, Jacobus AP, Wassermann GF. Rapid signaling responses in Sertoli cell membranes induced by follicle stimulating hormone and testosterone: Calcium inflow and electrophysiological changes. Life Sci 2011; 89(15-16): 577-83.
[67] Walker WH, Cheng J. FSH and testosterone signaling in Sertoli cells. Reproduction 2005; 130(1): 15-28.
[68] Walker WH. Non-classical actions of testosterone and spermatogenesis. Philos Trans R Soc Lond B Biol Sci 2010; 365(1546): 1557-69.
[69] Loss ES, Jacobsen M, Costa ZS, Jacobus AP, Borelli F, Wassermann GF. Testosterone modulates K(+)ATP channels in Sertoli cell membrane via the PLC-PIP2 pathway. Horm Metab Res 2004; 36(8): 519-25.
[70] Dumasia K, Kumar A, Deshpande S, Balasinor NH. Estrogen, through estrogen receptor 1, regulates histone modifications and chromatin remodeling during spermatogenesis in adult rats. Epigenetics 2017; 12(11): 953-63.